Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | GMNN | O75496 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3246553 | 0.97 | TSHR (0.33) | TSHRALDH1A1MAPK1CYP3A4CYP2D6 | |
| SCHEMBL5984673 | 0.89 | — | — | |
| SCHEMBL10537874 | 0.82 | — | — | |
| SCHEMBL56255 | 0.82 | — | — | |
| SCHEMBL599901 | 0.82 | TSHR (0.47) | TSHRALDH1A1MAPK1CYP3A4CYP2D6 | |
| SCHEMBL23846021 | 0.78 | TSHR (0.44) | TSHRALDH1A1MAPK1CYP3A4CYP2D6 | |
| SCHEMBL31380967 | 0.78 | TSHR (0.44) | TSHRALDH1A1MAPK1CYP3A4CYP2D6 | |
| SCHEMBL17274592 | 0.78 | TSHR (0.44) | TSHRALDH1A1MAPK1CYP3A4CYP2D6 | |
| SCHEMBL19819960 | 0.78 | TSHR (0.44) | TSHRALDH1A1MAPK1CYP3A4CYP2D6 | |
| SCHEMBL8612234 | 0.75 | TSHR (0.32) | TSHRALDH1A1MAPK1CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10202322-B2 | Resorcinol derivatives | SUTTER BAY HOSPITALS (US) | 2019-02-12 | — | — | US | claimed |
| US-20180170846-A1 | RESORCINOL DERIVATIVES | SUTTER WEST BAY HOSPITALS | 2018-06-21 | — | — | US | claimed |
| US-20130209483-A1 | CANNABIDINOID DERIVATIVES | SUTTER WEST BAY HOSPITALS (US) | 2013-08-15 | — | — | US | claimed |
| US-20090203699-A1 | AMINOMETHYLPYRIDINE DERIVATIVES, METHOD FOR PREPARING SAME AND THERAPEUTIC USE THEREOF | SANOFI-AVENTIS | 2009-08-13 | — | — | US | claimed |
| CN-101421240-A | Aminomethylpyridine derivatives, their preparation and use in therapy | SANOFI AVENTIS (FR) | 2009-04-29 | — | — | CN | claimed |
| EP-2010492-A2 | AMINOMETHYL PYRIDINE DERIVATIVES, METHOD FOR PREPARING SAME AND THERAPEUTIC USE THEREOF | Sanofi-Aventis (FR) | 2009-01-07 | — | — | EP | claimed |
| WO-2007119001-A2 | AMINOMETHYL PYRIDINE DERIVATIVES, METHOD FOR PREPARING SAME AND THERAPEUTIC USE THEREOF | SANOFI-AVENTIS (FR) | 2007-10-25 | — | — | WO | claimed |
| US-4301083-A | BY REACTION WITH AN ORGANIC CHLORIDE OR BROMIDE IN THE PRESENCE OF SODIUM OR POTASSIUM HYDROXIDE | KURARAY CO., LTD. (JP) | 1981-11-17 | — | — | US | claimed |
| US-12037660-B2 | Use of synergistic mixture of extractants for extracting rare earth elements from an aqueous medium comprising phosphoric acid | Commissariat à l'énergie atomique et aux énergies alternatives (FR) | 2024-07-16 | — | — | US | disclosed |
| CN-115885026-B | Viscosity index improver composition and lubricating oil composition | 三洋化成工业株式会社 | 2024-06-21 | — | — | CN | disclosed |
| WO-2024056517-A1 | USE OF AN ALKYLETHER SULFATE FOR IMPROVING THE EFFICACY OF HERBICIDES | BASF SE (DE) | 2024-03-21 | — | — | WO | disclosed |
| CN-113396144-B | Polymer compound and method for producing same, composition and method for producing same, resin composition, additive for lubricating oil, and lubricating oil | 三菱化学株式会社 | 2024-01-12 | — | — | CN | disclosed |
| CN-117098788-A | Resin composition, film and copolymer | 住友化学株式会社 | 2023-11-21 | — | — | CN | disclosed |
| US-20230340357-A1 | VISCOSITY INDEX IMPROVER COMPOSITION AND LUBRICATING OIL COMPOSITION | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2023-10-26 | — | — | US | disclosed |
| EP-0423764-A2 | Silver halide colour photographic material and cyan coupler of the 2-phenylureido-5-acylaminophenol type | FUJI PHOTO FILM CO., LTD. (JP) | 1991-04-24 | — | — | EP | disclosed |
| EP-0083311-B1 | 2,3-DIHYDROPERIMIDINES AS ANTIOXIDANTS FOR LUBRICANTS | CIBA-GEIGY AG (CH) | 1986-08-13 | — | — | EP | disclosed |
| EP-0083311-A2 | 2,3-Dihydroperimidines as antioxidants for lubricants | CIBA-GEIGY AG (CH) | 1983-07-06 | — | — | EP | disclosed |
| US-4389321-A | 2,3-Dihydroperimidines as antioxidants for lubricants | CIBA-GEIGY CORPORATION (US) | 1983-06-21 | — | — | US | disclosed |
| US-4301083-A | BY REACTION WITH AN ORGANIC CHLORIDE OR BROMIDE IN THE PRESENCE OF SODIUM OR POTASSIUM HYDROXIDE | KURARAY CO., LTD. (JP) | 1981-11-17 | — | — | US | disclosed |
| US-3956408-A | CARBON MONOXIDE, METAL SALT CATALYST | ETHYL CORPORATION (US) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203699-A1 | AMINOMETHYLPYRIDINE DERIVATIVES, METHOD FOR PREPARING SAME AND THERAPEUTIC USE THEREOF | TPMT, QDPR, HNMT | TSHR 4190/4885ALDH1A1 388/4885MAPK1 4344/4885 |
| US-10202322-B2 | Resorcinol derivatives | CNR1, CNR2, RCOR1 | TSHR 3290/4885ALDH1A1 1955/4885MAPK1 3453/4885 |
| US-20130209483-A1 | CANNABIDINOID DERIVATIVES | CNR2, CNR1, GPR18 | TSHR 4095/4885ALDH1A1 3491/4885MAPK1 3372/4885 |
| US-20180170846-A1 | RESORCINOL DERIVATIVES | CNR1, CNR2, RCOR1 | TSHR 3290/4885ALDH1A1 1955/4885MAPK1 3453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.